#IDXPosts

🤖 Dr. Bradley Langford presents ideas on how we can leverage AI to assist ID clinicians in stewardship initiatives!

💭 “Once a new technology rolls over you, if you're not part of the steamroller, you're part of the road.”
~ Stewart Brand

#ESCMIDGlobal2026 #IDXPosts #AI #ASP

🎊 Simply AMAZING to see so many of our members and colleagues at tonight’s social event in Munich, Germany!!! 🇩🇪🍻

✈️ For those returning home, we wish you safe travels the next few days!

@SIDPharm @accpinfdprn

#ESCMIDGlobal2026 #IDXPosts

I'm afraid you're missing so much esp if you are interested in ID #idsky vs #IDXposts

🩸The Surviving Sepsis Campaign group recently updated their guidelines in 2026!

⏱️ Dr. Willem Joost Wiersinga helps us review the timing and duration of antibiotic administration!

#ESCMIDGlobal2026 #IDXPosts #survivingsepsis #sepsis

💊 Dr. Ili Margalit presents key antimicrobial agents for TB, NTM, and Novartis infections! Great review especially with recent updates in TB management and the addition of Moxifloxacin to recommended regimens.

#ESCMIDGlobal2026 #IDXPosts #TB #nocardia

⭐️ Excellent table from Dr. Giusey Tiseo outlining key studies researching IV-to-PO stepdown!

🏥 All three studies showed a decreased LOS in the IV-to-PO stepdown group!

#ESCMIDGlobal2026 #IDXPosts #IVtoPO #Stepdowntherapy

🔬 Poster sessions started today!!! Who else is here to learn more about the AWESOME research that’s going on?! 🙋🏻‍♂️🙋🏼‍♀️

#ESCMIDGlobal2026 #Research #IDXPosts

🧪 Great review on severe community-acquired MRSA and PSAR pneumonia risk factors by Dr. Pedro Povoa!

#ESCMIDGlobal2026 #IDXPosts #Pneumonia

🤔 Do you use ciprofloxacin TDM at your institution?

🔬 Dr. Koch presents excellent research showing how 400 mg TID may not be sufficient in reaching appropriate levels in the body!

#IDXPosts #ESCMIDGlobal2026 #PKPD #Research

🧠 Penetration ability of drugs greatly affects the concentration at difficult to reach infection sites like the CSF!

💥 Mind-blowing to see how a serum concentration of 30 mg/L was equivalent to just 4 mg/L in the CSF in Dr. König’s case!

#PKPD #IDXPosts #ESCMIDGlobal2026

📈 PK/PD of drugs is a key consideration in appropriate antimicrobial dosing, especially in special populations!

➡️ Very excited for Drs. Christina König and Brigit Koch for brining us through this insightful journey!

#ESCMIDGlobal2026 #IDXPosts #PKPD #Research

☠️ Mortality is not enough!

🔬Several other factors are just as important to look at with clinical research!

#IDXPosts #ESCMIDGlobal2026 #research

Infectious diseases research endpoints such as mortality are the most common outcomes observed.

But what if we don’t have to use mortality all the time?

Drs. Calbo and Katsounas provided excellent info on ways we can include other outcomes in research!

#IDXPosts #ESCMIDGlobal

🌅 The day has come!

🦠 ESCMID Global 2026 starts TODAY!

🇩🇪 Whether you’re attending in-person or online, there are so many sessions to attend and learn from! We hope to see some of you here!

#IDXPosts #ESCMIDGlobal2026 #infectiousdiseases #research #munich

3 Important Things to Know About Antibiotics This Antibiotic Awareness Week, learn when you might need an antibiotic — and when these medications won’t help

Happy #USAAW25 from the antimicrobial stewardship team at @doh.wa.gov! We created a blog post to educate patients and the general public (amongst other fun plans we have for the week!): medium.com/wadepthealth...
#IDXposts #WAAW25 #BeAntibioticsAware

#idboardreview #idxposts 45 M from Connecticut presents in June with fever, chills, headache, myalgia. No focal deficits. Faint macular rash on distal ext, wbc 2700, plt80k, AST140 ALT115 #meded #idmeded #idsky

Don’t know much about geography? Decision support for the evaluation of patients with suspected high consequence infectious diseases | Antimicrobial Stewardship & Healthcare Epidemiology | Cambrid... Don’t know much about geography? Decision support for the evaluation of patients with suspected high consequence infectious diseases - Volume 5 Issue 1

Fantastic #decision_support_system to assess patients coming from abroad for #HCID (high consequences #infectious #diseases). Designed for #UnitedStates #physicians but useful even for specialists of other continents as #Europe.

#IDXposts

www.cambridge.org/core/journal...

🎥On demand | APSCMI / biomerieux E-learning

ICYMI - Experts introduce the free Microbiology in Clinical Practice course and explain how it can enhance your clinical knowledge.
youtu.be/-0vqLn3NCtA
#IDXposts #clinicalmicro
@biomerieux.com

Happy ID Pharmacists day 🥳🥳‼️This year's theme is  "Innovation in ID: Pharmacists Leading the Way."  Please join the discussion on Bluesky with SIDP between 12-1 PM EST today 🦠🧫💊#IDPharmacistsDay, #SIDPAdvocacy, #FutureOfIDPharmacy, #PharmacistsLeadingChange, #IDXposts

Too Much Coffee: A Rare Cause of Sore Throat A 25-year-old male from Guatemala presented to the clinic with a 5-year history of sore throat, associated with odynophagia and dysphagia for solids. He re

A 25 yo man from Guatemala with 5y sore throat, odynophagia & oral papules.
Biopsy: non-necrotizing granulomas, multinucleated cells + budding yeasts.
All cultures neg x8w.
Hx: childhood exposure to coffee crop soil.
What’s your differential?! #idsky #idxposts academic.oup.com/cid/article-...

*Navigating the new landscape of infectious diseases*

ISAC President, Prof. Souha Kanj, participated in this highly scientific conference in Catania with colleagues from around the world including ISAC committee member Prof. Macro Falcone
Well done to all involved!
#IDXposts
@souhakanj.bsky.social

The article is getting so much attention from the ID community #idsky #idxposts

Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria | Journal of Clinical Microbiology Rezafungin is a second-generation echinocandin that has shown activity against a range of Candida species including wild-type and azole- and echinocandin-resistant isolates (1–3). Rezafungin has improved chemical and biological properties that are distinct from other echinocandins. Most notably, the modified backbone of rezafungin leads to a stable chemical structure with reduced metabolism and degradation relative to other echinocandins. This results in a longer half-life, which allows for weekly dosing, improved tissue penetration, and reduced organ toxicity (4, 5). Less frequent dosing also results in high front-loaded exposure, which, along with good distribution to and penetration at infection sites may allow earlier mycological clearance from sites of infection with the potential to prevent the emergence of resistance (4, 6–10). Rezafungin was approved in 2023 by the United States Food and Drug Administration for the treatment of candidemia and invasive candidiasis based on clinical efficacy and safety data from the randomized Phase 2 STRIVE and Phase 3 ReSTORE clinical trials (10–12).

🆕💫 #JCM
Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria #IDXposts
@absteward.bsky.social
journals.asm.org/doi/abs/10.1...

Delighted to share the recent webinar held with
@escmid.bsky.social on #AMR in low resource settings and / or displaced populations

Over 1,600 people registered for the live event which was attended by colleagues from 134 countries
Watch now ⬇
youtu.be/X4D2fzqh9-w
#idxposts @souhakanj.bsky.social

Excellent editorial✨
@drandrekalil.bsky.social
Is Antibiotic De-Escalation Safe and Beneficial to Patients with Sepsis? #IDXposts academic.oup.com/cid/article-... #idsky #medsky

Thanks, more interactive , people repost more. Here more lurkers
#idxposts 🔥
#idsky

“The Internet was not designed to give us what we need. It was designed to give us what we want.”

This platform I tend to use it for my “thinking brain,” whereas other social media sites for my “feeling brain.”

I wonder if we’re able to convert to BlueSky #idtwitter #idxposts #idbluesky?

Thanks for your kind words, means alot to me coming from you!
See you in the other universe #idxposts #idsky

Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal Abstract. Non-bacterial thrombotic endocarditis (NBTE), formerly recognized as marantic endocarditis, represents a rare cardiovascular pathology intricatel

🆕️⚡️⚡️Non-bacterial thrombotic endocarditis (NBTE), formerly recognized as marantic endocarditis, represents a rare cardiovascular pathology intricately linked with hypercoagulable states, notably malignancy and autoimmune disorders. #idsky #idxposts
academic.oup.com/eurheartj/ar...